Report cover image

Global Spatial Proteomics Market Size Study, By Product (Instruments, Consumables, Software), By Technology (Imaging-Based, Mass Spectrometry-Based, Sequencing-Based), By Workflow (Sample Preparation, Instrumental Analysis, Data Analysis), By Sample Type

Publisher Bizwit Research & Consulting
Published Jan 13, 2025
Length 285 Pages
SKU # BIZW19503017

Description

Global Spatial Proteomics Market Size Study, By Product (Instruments, Consumables, Software), By Technology (Imaging-Based, Mass Spectrometry-Based, Sequencing-Based), By Workflow (Sample Preparation, Instrumental Analysis, Data Analysis), By Sample Type (FFPE, Fresh Frozen), By End-Use (Academic & Translational Research Institutes, Pharmaceutical & Biotechnology Companies), and Regional Forecasts 2022-2032


The Global Spatial Proteomics Market was valued at USD 77.6 million in 2023 and is expected to grow at a CAGR of 14.76% over the forecast period 2024-2032, reaching USD 267.9million by 2032. The market’s rapid expansion is fueled by advancements in imaging technologies, sequencing platforms, and increasing adoption in personalized medicine, oncology, and biomarker discovery.

Spatial proteomics, which enables the visualization and quantification of proteins within native tissue environments, is transforming biomedical research. Technologies such as Imaging Mass Cytometry (IMC), Multiplexed Ion Beam Imaging (MIBI), and next-generation sequencing (NGS) are at the forefront, facilitating high-resolution, spatially-resolved protein analysis. The adoption of spatial proteomics in cancer research has been particularly impactful, aiding the study of tumor microenvironments and advancing targeted therapies.

The growing need for data-driven precision medicine, coupled with increasing R&D investments by pharmaceutical and biotechnology companies, is a significant driver of market growth. Additionally, innovations such as Curio Bioscience’s Curio Seeker and NanoString’s GeoMx IO Proteome Atlas have strengthened the market by expanding capabilities for high-throughput protein mapping.

North America dominated the market in 2024, accounting for 49.13% of the global share, driven by advanced research infrastructure and significant funding. Asia-Pacific is expected to exhibit the fastest growth due to rising investments in healthcare, expanding research capabilities, and increasing adoption of spatial proteomics technologies in China, Japan, and India.

Major market players included in this report are:
• 10X Genomics
• Bruker
• NanoString Technologies, Inc.
• Akoya Biosciences, Inc.
• Fluidigm Corporation
• PerkinElmer
• Danaher
• Biotechne
• S2 Genomics, Inc.
• Seven Bridges Genomics Inc.
• Lunaphore Technologies
• Cayman Chemical
• Navinci Diagnostics
• Thermo Fisher Scientific
• Cytiva

The detailed segments and sub-segments of the market are explained below:

By Product:
• Instruments
Automated
Semi-Automated & Manual
• Consumables
• Software

By Technology:
• Imaging-Based Technologies
• Mass Spectrometry-Based Technologies
• Sequencing-Based Technologies
• Other Technologies

By Workflow:
• Sample Preparation
• Instrumental Analysis
• Data Analysis

By Sample Type:
• FFPE
• Fresh Frozen

By End-Use:
• Academic & Translational Research Institutes
• Pharmaceutical & Biotechnology Companies
• Other End-Use

By Region:

North America
• U.S.
• Canada
• Mexico

Europe
• UK
• Germany
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway

Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Thailand

Latin America
• Brazil
• Argentina

Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait

Years considered for the study are as follows:
• Historical Year: 2022
• Base Year: 2023
• Forecast Period: 2024-2032

Key Takeaways:
• Technology Trends: Imaging-based technologies accounted for the largest share, while sequencing-based technologies are expected to grow at the fastest CAGR.
• Key Applications: Cancer research and personalized medicine are driving market demand, particularly in drug discovery and biomarker identification.
• Regional Leadership: North America led the market in 2024 with 49.13% share, while Asia-Pacific is poised for the fastest growth over the forecast period.
• Major Players: Leading market players include 10X Genomics, Bruker, NanoString Technologies, Akoya Biosciences, and PerkinElmer.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Table of Contents

285 Pages
Chapter 1. Global Spatial Proteomics Market Executive Summary
1.1. Global Spatial Proteomics Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product
1.3.2. By Technology
1.3.3. By Workflow
1.3.4. By Sample Type
1.3.5. By End-Use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Spatial Proteomics Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Spatial Proteomics Market Dynamics
3.1. Market Drivers
3.1.1. Growing adoption of spatial proteomics in cancer research and drug discovery
3.1.2. Technological advancements in imaging and sequencing platforms
3.1.3. Increasing demand for personalized medicine
3.2. Market Challenges
3.2.1. High costs associated with spatial proteomics technologies
3.2.2. Limited awareness and accessibility in emerging markets
3.3. Market Opportunities
3.3.1. Growing applications in neuroscience, immunology, and infectious diseases
3.3.2. Expansion of spatial proteomics in Asia-Pacific and Latin America
Chapter 4. Global Spatial Proteomics Market Industry Analysis
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s Five Forces Model
4.1.7. Porter’s Five Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Spatial Proteomics Market Size & Forecasts by Product (2022-2032)
5.1. Segment Dashboard
5.2. Instruments
5.2.1. Automated
5.2.2. Semi-Automated & Manual
5.3. Consumables
5.4. Software
Chapter 6. Global Spatial Proteomics Market Size & Forecasts by Technology (2022-2032)
6.1. Segment Dashboard
6.2. Imaging-Based Technologies
6.3. Mass Spectrometry-Based Technologies
6.4. Sequencing-Based Technologies
6.5. Other Technologies
Chapter 7. Global Spatial Proteomics Market Size & Forecasts by Workflow (2022-2032)
7.1. Segment Dashboard
7.2. Sample Preparation
7.3. Instrumental Analysis
7.4. Data Analysis
Chapter 8. Global Spatial Proteomics Market Size & Forecasts by Sample Type (2022-2032)
8.1. Segment Dashboard
8.2. FFPE
8.3. Fresh Frozen
Chapter 9. Global Spatial Proteomics Market Size & Forecasts by End-Use (2022-2032)
9.1. Segment Dashboard
9.2. Academic & Translational Research Institutes
9.3. Pharmaceutical & Biotechnology Companies
9.4. Other End-Uses
Chapter 10. Global Spatial Proteomics Market Size & Forecasts by Region (2022-2032)
10.1. North America
10.1.1. U.S.
10.1.2. Canada
10.1.3. Mexico
10.2. Europe
10.2.1. UK
10.2.2. Germany
10.2.3. France
10.2.4. Italy
10.2.5. Spain
10.2.6. Denmark
10.2.7. Sweden
10.2.8. Norway
10.2.9. Rest of Europe
10.3. Asia-Pacific
10.3.1. China
10.3.2. Japan
10.3.3. India
10.3.4. South Korea
10.3.5. Australia
10.3.6. Thailand
10.3.7. Rest of Asia-Pacific
10.4. Latin America
10.4.1. Brazil
10.4.2. Argentina
10.4.3. Rest of Latin America
10.5. Middle East & Africa
10.5.1. Saudi Arabia
10.5.2. UAE
10.5.3. South Africa
10.5.4. Kuwait
10.5.5. Rest of Middle East & Africa
Chapter 11. Competitive Intelligence
11.1. Key Company SWOT Analysis
11.1.1. 10X Genomics
11.1.2. Bruker
11.1.3. NanoString Technologies, Inc.
11.2. Top Market Strategies
11.3. Company Profiles
11.3.1. 10X Genomics
11.3.2. Bruker
11.3.3. NanoString Technologies, Inc.
11.3.4. Akoya Biosciences, Inc.
11.3.5. PerkinElmer
11.3.6. Fluidigm Corporation
11.3.7. Danaher
11.3.8. Biotechne
11.3.9. Lunaphore Technologies
11.3.10. Seven Bridges Genomics Inc.
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
List of Tables
1. Global Spatial Proteomics Market Estimates & Forecasts by Region (2022-2032)
2. Global Spatial Proteomics Market Estimates & Forecasts by Product (2022-2032)
3. Global Spatial Proteomics Market Estimates & Forecasts by Technology (2022-2032)
4. North America Spatial Proteomics Market by Product (2022-2032)
5. Europe Spatial Proteomics Market by Technology (2022-2032)
6. Asia-Pacific Spatial Proteomics Market by Workflow (2022-2032)
7. Top Key Players and Revenue Analysis
List of Figures
1. Global Spatial Proteomics Market Size (2022 & 2032)
2. Regional Market Share Analysis, 2024
3. Product Trends: Instruments, Consumables, Software
4. Technology Trends: Imaging-Based, Sequencing-Based
5. Workflow Analysis: Sample Preparation and Instrumental Analysis
6. End-Use Market Share Analysis
7. Asia-Pacific Market Growth Forecast
This list is not complete; the final report contains more than 50 figures.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us